Valuation: Yixintang Pharmaceutical Group Co., Ltd.

Market Cap 6.56B 976M 837M 783M 715M 1.35B 93.46B 1.36B 9.26B 3.6B 46.93B 3.66B 3.59B 155B P/E 2026 *
12.2x
P/E 2027 * 10.3x
Enterprise Value 5.22B 777M 666M 623M 569M 1.07B 74.38B 1.09B 7.37B 2.87B 37.35B 2.92B 2.85B 124B EV / Sales 2026 *
0.29x
EV / Sales 2027 * 0.26x
Free-Float
51.88%
Yield 2026 *
4.15%
Yield 2027 * 4.67%
1 day-1.55%
1 week-4.35%
Current month-2.06%
1 month+4.38%
3 months-2.47%
6 months-15.83%
Current year-11.12%
1 week 11.4
Extreme 11.4
11.96
1 month 10.83
Extreme 10.83
12.91
Current year 9.41
Extreme 9.41
14.8
1 year 9.41
Extreme 9.41
15.36
3 years 9.41
Extreme 9.41
26.45
5 years 9.41
Extreme 9.41
41.55
10 years 9.41
Extreme 9.41
50.1
Manager TitleAgeSince
Chief Executive Officer 48 22/11/2023
President 60 25/11/2019
Director of Finance/CFO 44 22/11/2023
Director TitleAgeSince
Chairman 60 01/06/2009
Chairman 61 01/06/2009
Director/Board Member 44 16/11/2016
Date Insider Type Main position Quantity % Market Cap.
11/05/26 Buy

Founder

4,371,400 1.0926%
18/12/25 Buy

Founder

1,550,700 0.3876%
17/12/25 Buy

Founder

2,004,500 0.5010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.55%-4.35%-24.60%-49.71% 976M
+1.66%-1.45%-41.50%-12.98% 15.19B
+1.91%-1.69%-43.96%-29.67% 6.48B
+0.68%+4.52%-15.50%-10.06% 6.38B
-1.17%-1.46%-3.63%-24.10% 4.26B
+0.11%+0.97%-18.03%-39.45% 3.25B
-1.70%-2.31%+0.40%-34.91% 2.94B
-3.91%-3.99%-48.00%-28.16% 2.93B
+0.23%-3.92%-15.76%-5.88% 2.55B
-0.61%-0.79%+46.18% - 2.39B
Average -0.44%-1.89%-16.44%-26.10% 4.74B
Weighted average by Cap. +0.39%-2.27%-24.95%-20.75%

Financials

2026 *2027 *
Net sales 18.05B 2.68B 2.3B 2.15B 1.97B 3.71B 257B 3.75B 25.47B 9.9B 129B 10.08B 9.86B 427B 19.16B 2.85B 2.44B 2.28B 2.09B 3.94B 273B 3.98B 27.03B 10.51B 137B 10.7B 10.47B 453B
Net income 545M 81.08M 69.49M 65.01M 59.43M 112M 7.76B 113M 769M 299M 3.9B 304M 298M 12.9B 650M 96.63M 82.81M 77.47M 70.83M 134M 9.25B 135M 917M 356M 4.65B 363M 355M 15.37B
Net Debt -1.34B -199M -171M -160M -146M -276M -19.08B -279M -1.89B -735M -9.58B -748M -732M -31.7B -1.63B -243M -208M -194M -178M -335M -23.22B -339M -2.3B -895M -11.66B -911M -891M -38.58B
Logo Yixintang Pharmaceutical Group Co., Ltd.
Yixintang Pharmaceutical Co Ltd, formerly Yunnan Hongxiang Yixintang Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical retail chains. The Company is also engaged in major health industries such as pharmaceutical distribution, traditional Chinese medicine industry, medical business, convenience goods, personal care and beauty. The Company's main products include regular decoction pieces, direct oral decoction pieces, active ingredients, ultrafine powders, toxic decoction pieces, and formula granules. The Company mainly operates five major brands: Hongxiang, Shanshang, Huipin, Bendian and Hanzun. The Company mainly operates its businesses in the domestic market.
Employees
34,848
Date Price Change Volume
24/08/26 CN¥11.43 -1.55% 5,059,197
21/08/26 CN¥11.61 -2.44% 9,723,927
20/08/26 CN¥11.90 +3.03% 9,942,695
19/08/26 CN¥11.55 -1.53% 8,042,400
18/08/26 CN¥11.73 -1.84% 9,425,979
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
11.43CNY
Average target price
14.86CNY
Spread / Average Target
+30.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002727 Stock